School of Medicine


Showing 1-4 of 4 Results

  • Aussama Nassar, MD, MSc,FACS, FRCSC

    Aussama Nassar, MD, MSc,FACS, FRCSC

    Clinical Associate Professor, Surgery - General Surgery

    BioDr. Nassar holds board certifications in both General Surgery and Surgical Critical Care across the United States and Canada, demonstrating his unparalleled expertise in the field. Having obtained a Master of Science in Health Science Education from McMaster University in Canada, Dr. Nassar boasts an impressive educational background.

    Currently, he serves as the director of the Surgical Critical Care Fellowship Program at Stanford University and is also the founder and director of the Surgery Resident Coaching Program. With over 12 years of clinical academic experience in top-tier tertiary care referral academic health centers throughout North America, Dr. Nassar's wealth of knowledge is truly remarkable.

    His clinical passions encompass trauma, acute care surgery, critical care, and a specialized focus on abdominal wall reconstruction. As a dedicated clinician-educator, Dr. Nassar is a certified simulation educator an ATLS and ASSET course director. His research pursuits primarily revolve around the enhancement of surgical education, with a particular emphasis on the acquisition of non-technical skills in surgical training programs.

    Dr. Nassar is committed to developing innovative assessment tools for trainees and investigating burnout among physicians and other healthcare professionals. With a strong presence both nationally and internationally, his influence in the realm of surgical education continues to grow and shape the future of healthcare.

  • Rahim Nazerali, MD, MHS

    Rahim Nazerali, MD, MHS

    Clinical Associate Professor, Surgery - Plastic & Reconstructive Surgery

    BioDr. Nazerali specializes in complex reconstruction, microsurgery, and aesthetic and cosmetic surgery. He excels at breast reconstruction using free autologous tissue and performs advanced techniques such as the minimally invasive superficial inferior epigastric artery (SIEA) flap, as well as the deep inferior epigastric artery perforator (DIEP) flap procedure. In addition to autologous reconstruction, Dr. Nazerali utilizes the latest techniques in implant-based breast reconstruction. His techniques and results have made him a leading instructor and lecturer at national and international institutions, societies and conferences.

    In addition to breast reconstruction, Dr. Nazerali performs both aesthetic as well as whole body reconstructive procedures. He has a busy aesthetic practice focusing on breast augmentation, face and body rejuvenation as well as body contouring. In his reconstructive practice, he specializes in abdominal wall reconstruction as well as post-trauma tissue transfers. For every patient in his care, his goal is to optimize restoration of both form and function.

    To help advance the field of plastic and reconstructive surgery, Dr. Nazerali conducts research into outcomes of breast reconstruction, augmentation, and reduction. Dr. Nazerali has published widely: well over 100 journal articles and conference proceedings. Topics include breast reconstruction after radiation; advances in surgical technique; and, the use of virtual, augmented, and mixed reality systems in plastic surgery practice and education. His work has appeared in Annals of Plastic Surgery, Plastic and Reconstructive Surgery, Surgery, the European Journal of Plastic Surgery, the Aesthetic Surgery Journal, and elsewhere.

    Dr. Nazerali focuses not only on improving his patient’s lives but also our ability to deliver care as an institution. He is on the Medical Executive Council at Stanford Healthcare, serves as a committee member in the American Society of Plastic Surgeons as well as the California Society of Plastic Surgeons. In his spare time, he volunteers his time to provide reconstructive surgical services to adults and children in need worldwide.


    .

  • Dung Nguyen

    Dung Nguyen

    Clinical Professor, Surgery - Plastic & Reconstructive Surgery

    BioDr. Dung H Nguyen is currently the Director of Breast Reconstruction at the Stanford Women’s Cancer Center and the Director of Adult Plastics Clinic at Stanford Healthcare. She graduated with a Bachelor of Science in Biochemistry and highest academic honor and distinction from U.C. Davis. She earned a Pharm.D degree from U.C.S.F. School of Pharmacy and a MD degree from U.C.S.D. She then did a residency in general surgery and a residency in Plastic and Reconstructive Surgery at the University of Southern California (USC) Medical Center. She further completed a fellowship in microsurgery from Chang Gung Memorial Hospital in Taiwan, one of the largest reconstructive surgery centers in the world. She was recruited to Stanford from Cedar Sinai Medical Center in 2012, and is currently a Clinical Professor in the Division of Plastic and Reconstructive Surgery at Stanford University.

    Dr. Nguyen specializes in aesthetic and reconstructive breast surgery, surgical treatment of lymphedema including vascularized lymph node transfer and lymphaticovenous anastomosis, and complex tissue reconstruction utilizing microsurgery and supermicrosurgery. She also has interest in cosmetic surgery, including facial rejuvenation and body contouring procedures.

    In addition to her clinical commitment, Dr. Nguyen has basic science and clinical research interests in lymphedema and breast reconstruction. She has published articles in peer review journals, presented at national and international professional meetings and has authored book chapters in various plastic surgery textbooks. She also enjoys volunteering on overseas medical missions and participating in medical charity activities.

  • Jeffrey Norton, MD

    Jeffrey Norton, MD

    Robert L. and Mary Ellenburg Professor of Surgery, Emeritus

    Current Research and Scholarly InterestsInterleukin-12 is a Th1 cytokine. It is important in the cell mediated immune response. We are investigating its role as an anti-tumor cytokine to augment the immune response against cancer. We are planning a human trial.